Hims & Hers (HIMS) Falls as Key Executives Dispose Shares

We recently published 10 Stocks That Vanished in Value Hims & Hers Health, Inc. (NYSE:HIMS) is one of the worst-performing stocks on Tuesday.

Shares of telehealth company Hims & Hers Health dropped by 4.04 percent on Tuesday as investors mirrored a selloff from key executives of the company, which included none other than its CEO.

In a regulatory filing, Hims & Hers Health, Inc. (NYSE:HIMS) said its CEO, Andrew Dudum, sold $33.4 million of shares in the company, involving 660,000 units at a price of $50.58 apiece.

The transaction was aimed at cashing in on gains from the stock’s recent rally.

Despite the sale, Dudum remains the largest individual shareholder, owning 8 million indirect shares and 92,313 direct holdings in Hims & Hers Health, Inc. (NYSE:HIMS).

Meanwhile, other key executives also resorted to profit-taking in the past trading days.

In separate filings, Chief Legal Officer Soleil Boughton sold 2,572 shares at a price of $51.64 apiece for $132,818, while Chief Medical Officer Patrick Carroll disposed of 60,000 shares for a total of $3.2 million.

Since the start of the month, shares of Hims & Hers Health, Inc. (NYSE:HIMS) have already dropped by 27.5 percent.